← Back to Search

Behavioral Intervention

Intervention- Home-based Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

N/A

Waitlist Available

Led By Roberto P Benzo, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 40+

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3 months

Awards & highlights

Study Summary

This trial is comparing the effectiveness of two types of pulmonary rehabilitation programs.

Who is the study for?

This trial is for individuals over 40 years old who have been hospitalized due to Chronic Obstructive Pulmonary Disease (COPD) and are eligible for Pulmonary Rehabilitation (PR). Participants must feel confident (scoring above a 5 on a self-efficacy scale of 1-10) about using the system daily. Those unable to walk due to orthopedic-neurologic issues or being bedridden cannot join.Check my eligibility

What is being tested?

The study compares two approaches: home-based PR with new technology and health coaching, versus traditional referral to center-based PR which may also offer telehealth options. The goal is to see which method better encourages patients to stick with their rehabilitation after leaving the hospital.See study design

What are the potential side effects?

Since this intervention involves exercise and health coaching rather than medication, side effects might include muscle soreness or fatigue from physical activity. However, specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to Pulmonary Rehabilitation

Secondary outcome measures

Daily Physical Activity

Duke-UNC Functional Social Support Questionnaire (FSSQ)

Health Care Utilization

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention- Home Pulmonary RehabilitationExperimental Treatment1 Intervention

Participants enrolled in the intervention arm will be offered a Home-based pulmonary rehabilitation program with health coaching.

Group II: Control- ChoiceActive Control1 Intervention

This arm receives the standard of care which includes the choice of PR at a facility or through telehealth. Center based PR involves attending a medical center gym where they can do exercises and receive disease specific education. Telehealth PR is delivered virtually through the computer or telephone.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Intervention- Home-based Pulmonary Rehabilitation

2018

N/A

~10

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,834 Previous Clinical Trials

47,310,339 Total Patients Enrolled

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,766,787 Total Patients Enrolled

Roberto P Benzo, MDPrincipal InvestigatorMayo Clinic

2 Previous Clinical Trials

36 Total Patients Enrolled

Media Library

Home-based Pulmonary Rehabilitation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04521608 — N/A

Chronic Obstructive Pulmonary Disease Research Study Groups: Control- Choice, Intervention- Home Pulmonary Rehabilitation

Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Home-based Pulmonary Rehabilitation Highlights & Side Effects. Trial Name: NCT04521608 — N/A

Home-based Pulmonary Rehabilitation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04521608 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit to the number of individuals enrolled in this clinical trial?

"Right. According to clinicaltrials.gov, the trial that first went up on November 30th 2020 is currently in search of recruits and was most recently edited on June 28th 2022. The study requires 150 participants at a single location."

Answered by AI

Is enrollment for this research endeavor still open?

"According to the information found on clinicaltrials.gov, this particular trial is currently recruiting participants. It was first made available for public view on November 30th 2020 and most recently revised June 28th 2022."

Answered by AI